Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMDZ | HELP | RLMD | ||
| Company | Immune Design CS | Cybin Inc | Relmada Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.84 | 6.04 | 3.90 | ||
| High | 5.85 | 6.20 | 3.93 | ||
| Low | 5.84 | 5.98 | 3.72 | ||
| Latest | 5.85 | 6.09 | 3.72 | ||
| Change | unch | +0.17 | -0.18 | ||
| % Change | unch | +2.87% | -4.62% | ||
| Volume | 103,800 | 293,500 | 198,800 | ||
| 20-Day Average Volume | 409,005 | 466,395 | 565,105 | ||
| Previous Close | 5.85 | 5.92 | 3.90 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.84 | 6.81 | 3.87 | ||
| 20-Day Raw Stochastic | 100.00% | 14.25% | 38.14% | ||
| 20-Day Relative Strength | 88.63 | 41.39 | 46.42 | ||
| Weighted Alpha | -20.50 | -33.90 | +209.58 | ||
| Today's Opinion | 88% Buy | 40% Sell | 40% Buy | ||
| Previous Opinion | 88% Buy | 40% Sell | 56% Buy | ||
| Last Month's Opinion | 56% Buy | 56% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/25/19 | +1.84% since 02/06/26 | -4.12% since 02/06/26 | ||
| Low | 5.84 on 04/01/19 | 5.76 on 02/09/26 | 3.71 on 02/12/26 | ||
| High | 5.85 on 04/01/19 | 7.19 on 02/10/26 | 4.35 on 02/09/26 | ||
| 1-Month | |||||
| %Chg | +0.34% since 03/01/19 | -21.22% since 01/13/26 | -8.37% since 01/13/26 | ||
| Low | 5.82 on 03/14/19 | 5.76 on 02/09/26 | 3.22 on 02/04/26 | ||
| High | 5.85 on 04/01/19 | 8.23 on 01/15/26 | 4.53 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | +350.00% since 12/31/18 | +2.53% since 11/13/25 | -4.12% since 11/13/25 | ||
| Low | 1.22 on 01/03/19 | 5.50 on 12/02/25 | 3.22 on 02/04/26 | ||
| High | 5.85 on 04/01/19 | 9.12 on 12/30/25 | 5.12 on 11/19/25 | ||
| 6-Month | |||||
| %Chg | +73.08% since 10/01/18 | -19.87% since 08/13/25 | +554.70% since 08/13/25 | ||
| Low | 1.10 on 12/24/18 | 5.50 on 12/02/25 | 0.56 on 08/14/25 | ||
| High | 5.85 on 04/01/19 | 9.12 on 12/30/25 | 5.12 on 11/19/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 282,935 | 303,854 | 272,802 | ||
| Shares Outstanding, K | 48,365 | 49,894 | 73,334 | ||
| Annual Sales | 2,200,000 | 0 | 0 | ||
| Annual Net Income | -54,760,000 | -81,310,000 | -79,980,000 | ||
| Last Quarter Sales | 480,000 | 0 | 0 | ||
| Last Quarter Net Income | -13,600,000 | -33,720,000 | -10,090,000 | ||
| 60-Month Beta | 3.48 | 0.63 | 0.76 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.39 on 11/13/25 | -0.30 on 11/13/25 | ||
| Latest Earnings Date | 05/01/19 | 02/16/26 | 03/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||